Immunocore Holdings plc
IMCR
$30.45
-$0.28-0.91%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 24.30% | 29.22% | 29.93% | 33.16% | 19.80% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.30% | 29.22% | 29.93% | 33.16% | 19.80% |
| Cost of Revenue | -20.48% | 33.57% | 32.72% | 237.80% | -37.63% |
| Gross Profit | 21.83% | 20.64% | 23.41% | 32.44% | 30.74% |
| SG&A Expenses | 0.76% | 11.95% | 10.75% | 2.32% | 2.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -9.29% | -- | -- | -- | -2,112.37% |
| Total Operating Expenses | 22.22% | 24.92% | 23.43% | 0.52% | -3.02% |
| Operating Income | 102.64% | 15.66% | 7.13% | 86.35% | 92.19% |
| Income Before Tax | 36.37% | -95.01% | 4.30% | 125.27% | 3.20% |
| Income Tax Expenses | 1,458.67% | 118.20% | -59.22% | 197.20% | 82.24% |
| Earnings from Continuing Operations | -26.46% | -102.03% | 11.33% | 120.56% | -20.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.46% | -102.03% | 11.33% | 120.56% | -20.48% |
| EBIT | 102.64% | 15.66% | 7.13% | 86.35% | 92.19% |
| EBITDA | 470.64% | 14.65% | 6.19% | 89.16% | 98.61% |
| EPS Basic | -25.41% | -102.00% | 11.84% | 120.47% | -19.26% |
| Normalized Basic EPS | 25.32% | -95.01% | 4.82% | 102.55% | 19.04% |
| EPS Diluted | -25.41% | -102.06% | 11.84% | 120.41% | -19.08% |
| Normalized Diluted EPS | 25.32% | -94.73% | 4.82% | 102.45% | 19.04% |
| Average Basic Shares Outstanding | 0.84% | 0.76% | 0.56% | 0.42% | 1.04% |
| Average Diluted Shares Outstanding | 0.84% | -4.55% | 0.56% | 4.16% | 1.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |